Your browser doesn't support javascript.
loading
Managing Drug-Drug Interaction Between Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Mycophenolate Mofetil.
Lemaitre, Florian; Ben Ali, Zeineb; Tron, Camille; Jezequel, Caroline; Boglione-Kerrien, Christelle; Verdier, Marie-Clémence; Guyader, Dominique; Bellissant, Eric.
Affiliation
  • Lemaitre F; *Department of Clinical and Biological Pharmacology and Pharmacovigilance, Rennes University Hospital, Pharmacoepidemiology and Drug Information Center; †Laboratory of Experimental and Clinical Pharmacology, Faculty of Medicine, Rennes 1 University; ‡Inserm, CIC-P 1414 Clinical Investigation Center; and §Liver Disease Unit, Rennes University Hospital, Rennes, France.
Ther Drug Monit ; 39(4): 305-307, 2017 08.
Article in En | MEDLINE | ID: mdl-28700519
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Uracil / Carbamates / Hepatitis C / Ritonavir / Macrocyclic Compounds / Anilides / Mycophenolic Acid Type of study: Diagnostic_studies Limits: Aged / Humans / Male Language: En Journal: Ther Drug Monit Year: 2017 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Uracil / Carbamates / Hepatitis C / Ritonavir / Macrocyclic Compounds / Anilides / Mycophenolic Acid Type of study: Diagnostic_studies Limits: Aged / Humans / Male Language: En Journal: Ther Drug Monit Year: 2017 Type: Article Affiliation country: France